Exploratory definition of a clinically meaningful change in intracranial EEG features: Analysis of data from a long-term treatment study of the RNS® System
Epilepsy & Behavior · 2026
DOI: 10.1016/j.yebeh.2026.111248 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsy & Behavior, 2026. Verfasst von Arnold R Gammaitoni und 9 weiteren Autor:innen. Beteiligte Einrichtung: Rapport Therapeutics, Inc., Boston, MA, USA. Electronic address: gammaitoni2013@verizon.net. Hauptthemen laut MEDLINE: Anticonvulsants, Electrocorticography, Drug Resistant Epilepsy, Epilepsy. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
OBJECTIVE: Novel proof-of-concept designs utilizing biomarkers associated with an established clinically meaningful outcome are needed for antiseizure medication (ASM) efficacy assessment in patients with epilepsy, including drug-resistant focal epilepsy. Changes in long episode (LE) frequency, recorded by the responsive neurostimulator (RNS® System), are associated with changes in clinical seizure (CS) frequency following ASM initiation, suggesting that LEs may serve as a valid biomarker. Here, we aimed to establish the LE reduction magnitude associated with a clinically meaningful CS reduction. METHODS: Post hoc retrospective analyses of CS and LE frequencies, responder rate, and receiver operating characteristics from a long-term RNS open-label treatment study in patients who met predefined criteria were performed to evaluate the association between changes in LE and CS frequency and the LE reduction cutpoint associated with a ≥ 50% CS reduction. RESULTS: Patients (N=45) initiated clobazam (n=15), levetiracetam (n=4), or lacosamide (n=26). Patients achieved a median 30% LE and 50% CS reduction. Patients with
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rapport Therapeutics, Inc., Boston, MA, USA. Electronic address: gammaitoni2013@verizon.net.
- NeuroPace, Inc., Mountain View, CA, USA.
- Comprehensive Epilepsy Center, Department of Neurology, NYU Grossman School of Medicine, New York, NY, USA.
- Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, USA.
- PROMETRIKA, LLC, Cambridge, MA, USA.
- Mosaica Medicines, Boston, MA, USA.
Zitieren
APA
Gammaitoni, A. R., Morrell, M. J., French, J. A., Friedman, D., Davis, K. A., Tcheng, T. K., Seale, C. G., Stepanians, M., Galer, B. S., & Motley, W. W. (2026). Exploratory definition of a clinically meaningful change in intracranial EEG features: Analysis of data from a long-term treatment study of the RNS® System. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2026.111248
Vancouver
Gammaitoni AR, Morrell MJ, French JA, Friedman D, Davis KA, Tcheng TK, et al. Exploratory definition of a clinically meaningful change in intracranial EEG features: Analysis of data from a long-term treatment study of the RNS® System. Epilepsy & Behavior. 2026. doi:10.1016/j.yebeh.2026.111248
BibTeX
@article{Gammaitoni2026,
author = {Gammaitoni, Arnold R and Morrell, Martha J and French, Jacqueline A and Friedman, Daniel and Davis, Kathryn A and Tcheng, Thomas K and Seale, Cairn G and Stepanians, Miganush and Galer, Bradley S and Motley, William W},
title = {Exploratory definition of a clinically meaningful change in intracranial EEG features: Analysis of data from a long-term treatment study of the RNS® System},
journal = {Epilepsy & Behavior},
year = {2026},
doi = {10.1016/j.yebeh.2026.111248}
}
EUVIMED